Story

Ancora Lifts Offer for H.B. Fuller's Adhesives Unit to $1.4 Billion, Bloomberg Reports

ENTHMSVIIDZHZH-TWJAKOHI
Sep 29, 20262 min read
Ancora Lifts Offer for H.B. Fuller's Adhesives Unit to $1.4 Billion, Bloomberg Reports

Summary

Activist investor Ancora Holdings has reportedly raised its unsolicited cash bid for H.B. Fuller's building adhesives division to $1.4 billion, increasing pressure on the chemical maker's board after an initial rejection.

Text size
Background

Activist investor Ancora Holdings Group has increased its unsolicited cash offer for H.B. Fuller's (NYSE:FUL) building adhesives unit to as much as $1.4 billion, escalating pressure on the chemical company's board, according to a report from Bloomberg News. The revised proposal aims to bring H.B. Fuller's directors to the negotiating table after they rejected an earlier bid.

Details of the Increased Bid

The new offer represents a $200 million increase at the upper end of Ancora's previous proposal, which ranged from $1.1 billion to $1.2 billion. To underscore the bid's credibility and viability, Ancora has reportedly secured a highly confident letter for debt financing from Fortress Investment Group.

Ancora is pushing for a carve-out of what it considers a lower-margin division. The activist investor argues that a sale would unlock significant value for H.B. Fuller shareholders.

Strategic Rationale and Board's Position

The Cleveland-based activist firm contends that divesting the segment would allow H.B. Fuller to:

Sample IUX Markets – In-articleAd
  • Significantly pay down debt on its balance sheet.
  • Sharpen management's focus on its core specialty chemical operations.
  • Better integrate its recent acquisition of UK-based Advanced Medical Solutions Group Plc.

H.B. Fuller's board previously rebuffed Ancora’s initial approach, stating that the offer materially undervalued the business unit and its long-term growth potential. The board also cited a lack of execution details in its rejection.

Context and Market Reaction

The sweetened bid is the latest move in a campaign that began in May, when Ancora publicly criticized H.B. Fuller's acquisition of Advanced Medical Solutions as "risky and value-destructive." Ancora, which has a history of high-profile campaigns at companies like Norfolk Southern Corp., has warned it may pursue legal remedies if it believes the board is harming shareholder value.

Market reaction to the updated offer was subdued. According to the report, shares of H.B. Fuller dipped less than 1% in premarket trading on Tuesday.

Read next

More on Stocks
Back to latest news

LATEST